Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mbx Biosciences Inc (MBX)

Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mbx Biosciences Inc 11711 N. Meridian Street Suite 300 Carmel IN 46032 USA

https://mbxbio.com Employees: 43 P: 317-659-0200

Sector:

Medical

Description:

MBX Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company's pipeline includes its lead product candidate MBX 2109, MBX 1416 and MBX 4291. MBX Biosciences Inc. is based in CARMEL, Ind.

Key Statistics

Overview:

Market Capitalization, $K 1,819,878
Enterprise Value, $K 1,770,528
Shares Outstanding, K 44,902
Float, K 21,468
% Float 47.81%
Short Interest, K 3,844
Short Float 8.56%
Days to Cover 4.41
Short Volume Ratio 0.51
% of Insider Shareholders 52.19%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -61,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,620 K
EBIT, $ -90,880 K
EBITDA, $ -90,640 K

Growth:

1-Year Return 284.54%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.63 on 11/06/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -2.39
EPS Growth vs. Prev Qtr -8.62%
EPS Growth vs. Prev Year 77.34%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 12/31/69
Dividend Payout Ratio 0.00%

MBX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.28%
Return-on-Assets % -28.09%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.72
Book Value/Share 8.67
Interest Coverage -4.74
60-Month Beta 0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar